Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239551 · ClinicalTrials.gov registry record · Phase 4
Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00239551 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT00239551, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the prostaglandin levels in patients with stress ulcer and the effect of Prevacid on prostaglandin levels in patients with stress ulcer.
Interventions
- DRUG Prevacid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00239551
The ClinicalTrials.gov registry entry for NCT00239551 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prevacid is the first listed.
NCT00239551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00239551 about?
NCT00239551 is a clinical study titled "Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer". The purpose of this study is to measure the prostaglandin levels in patients with stress ulcer and the effect of Prevacid on prostaglandin levels in patients with stress ulcer.
What is the current status of trial NCT00239551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00239551?
The interventions under investigation include: Prevacid (DRUG).
Who is sponsoring clinical trial NCT00239551?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.